Publications by authors named "Sharvari W Joshi"

Claim this Profile
A
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.
Neal Van Hoeven, Christopher B Fox, Brian Granger, Tara Evers, Sharvari W Joshi

Sci Rep· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach.
Christopher B Fox, Mark T Orr, Neal Van Hoeven, Sarah C Parker, Traci J T Mikasa, Sharvari W Joshi

J Control Release· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.
Neal Van Hoeven, Sharvari Waghmare Joshi, Ghislain Ismael Nana, Angela Bosco-Lauth, Christopher Fox

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis